Chronicle Journal: Finance

Sono-Tek Announces Record Sales of $15.3 Million and Record Net Income of $1.1 Million for Fiscal Year 2020 and Provides First Quarter FY2021 Sales Guidance and FY2021 Outlook

Record Yearend Backlog of $3.5 Million for Fiscal Year 2020

  • Strong demand in leading markets drove a sales increase of 32.3% over fiscal 2019 to $15.3 million with gross margin of 48%, a 240 basis point improvement; For the fourth quarter, sales were up 88% over the prior-year period with gross margin of 48%, a 280 basis point improvement.
  • Higher net sales were driven by demand for highly customized ultrasonic coating systems in the electronics/microelectronics market, as well as increased sales in the medical market for stent coating machines.  The continued product line expansion towards more complex higher value machinery, at higher prices, was a major factor in this growth. 
  • Achieved record yearend backlog of $3.5 million, up 16% over the prior year from continued strong demand in the microelectronics/electronics, specialty glass, and medical markets. 
  • First quarter of fiscal 2021 sales growth is expected to increase approximately 21% from the prior year period with measurable conversion of sales to operating income and earnings.

MILTON, NY - (NewMediaWire) - May 29, 2020 - Sono-Tek Corporation (OTCQX: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fourth quarter and fiscal year ended February 29, 2020 (“fiscal 2020”).

Dr. Christopher L. Coccio, Chairman and CEO of Sono-Tek, commented, “During fiscal 2020, our strategy to expand the addressable market for our unique ultrasonic coating technology continued to gain traction, reflecting our ongoing development of new, complex solutions for the Alternative Energy, Microelectronics and Medical markets.  These more complex solutions address high value applications for our customers and provide economically compelling alternatives to traditional coating technologies.  We focused our sales and marketing resources on these targeted opportunities and, combined with strong market conditions, generated a sales increase of 32.3% to $15.3 million for the fiscal year.  

“The strong sales growth and 240 basis point improvement in gross margin increased our operating leverage and drove a nearly seven-fold increase in net income to a record $1.1 million for the year. We achieved this even as we continued to invest in advancing our technologies through new product development and adding to our experienced staff of application engineers to further fuel growth. 

“Our strong pipeline of opportunities gained momentum as well.  This momentum, combined with our record yearend backlog of $3.5 million, would normally provide us with confidence in our expectations for significant revenue growth in fiscal 2021.  However, COVID-19 broke out just as we began our new fiscal year in March 2020, making the full year's revenue more challenging to forecast.  With a strong pre-COVID-19 backlog in place, we now anticipate achieving a revenue increase of approximately 21% for the first quarter of the new fiscal year, which ends May 31, 2020.  This is slightly less than our prior forecasted Q1 growth, and results from a delayed shipment of 1 -2 weeks, due to COVID-19 related schedule challenges.  It is also possible to forecast an improved second quarter, with revenue growth of 15% - 20% compared to last fiscal year, as our business has evolved to larger projects with longer lead times. At this time though, we don’t believe that we will be able to maintain the same pace of growth in the last two quarters of the year compared to the same period of last fiscal year, due to the current economic uncertainty coupled with lower GDP and higher unemployment.  Therefore, the negative impacts of COVID-19 on our business are most likely to occur in the second half of FY2021 and first half of FY2022, unless the lockdowns ease on our customers and their consumers soon. We are continuing to work hard to accelerate our growth strategies and develop new business to offset the potential COVID-19 related declines and firmly believe that we will thrive in spite of the current economic issues due to our market leadership and successful history of developing our target markets,” concluded Dr. Coccio.

Fiscal 2020 Review (Results compared with fiscal 2019) 

 ($ in thousands)    Change
 FY 2020 FY 2019 $ %
Net Sales$   15,355  $   11,610  $     3,745 32%
Gross Profit$     7,313  $     5,249  2,064 39%
    Gross Margin47.6% 45.2%    
Operating Income $     1,115  $        82  1,033 1,260%
    Operating Margin7.3% 0.71%    
Net Income$     1,107  $        162  $        945 583%
    Net Margin7.2% 1.4%    

The introduction of several new high value machine offerings, in combination with our continued investment in application engineering capabilities, drove sales up 32% to $15,355,000, compared with the prior fiscal year.  

In fiscal 2020, approximately 71% of sales originated outside of the United States and Canada. This compares with 65% in fiscal 2019.  The geographic shift was mostly due to higher sales to Asian and European markets. 

Gross profit and operating margins for fiscal 2020 increased to 47.6% and 7.3%, respectively, from 45.2% and 0.71%, respectively, for fiscal 2019. The higher gross profit margin reflects a strong year in providing complex coating solutions with increased applications engineering value to our customers, as well as a shift in the mix of our markets. The shift in mix reflects increased sales to the microelectronics and medical sectors, whose products contain the highest value of our applications expertise and contributed to increased margins as well.

Sono-Tek achieved net income of $1.1 million, or $0.07 per share, basic and diluted, compared with $0.06 million, or $0.01 per share, basic and diluted, in the prior year. Weighted average fully diluted common shares outstanding were 15,359,088 and 15,218,913 in fiscal 2020 and fiscal 2019, respectively.

Fourth Quarter Fiscal 2020 Review (Results compared with the fourth quarter of fiscal 2019)

 ($ in thousands)    Change
 FY 2020 FY 2019 $ %
Net Sales$     5,514  $     2,936  $        2,578  88%
Gross Profit$     2,665  $     1,336          1,329  99%
    Gross Margin48.3% 45.5%    
Operating Income (Loss)$       749  $       (14)          763  5,450%
    Operating Margin14% (.46%)    
Net Income$        688  $        61  $        627  1,028%
    Net Margin12.5% 2.1%    

Balance Sheet and Cash Flow Overview

Net cash generated in operating activities was $3,254,000 in fiscal 2020, compared with usage of $109,000 cash in fiscal 2019. Capital expenditures in fiscal 2020 increased to $722,000 compared with $547,000 in the prior fiscal year. 

On February 29, 2020, the Company had total debt of $708,000, down $163,000 from fiscal 2019 year-end.  Total debt is approximately 7% of the Company’s total capitalization and is related to the mortgage on the industrial park where the Company’s manufacturing operations are located. 

Sono-Tek has a revolving credit line of $1,500,000 and a $750,000 equipment purchase facility, both of which had no outstanding borrowings at year-end.

On April 17, 2020, the Company entered into a loan transaction pursuant to which it received loan proceeds of $1,001,640 on May 8, 2020, under the Paycheck Protection Program (“PPP”). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act, provides for loans to qualifying companies and is administered by the U.S. Small Business Administration.

About Sono-Tek

Sono-Tek Corporation is the leading developer and manufacturer of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive.

The Company’s solutions are environmentally-friendly, efficient, and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity, and reduced emissions.

Sono-Tek’s growth strategy is focused on leveraging its innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop microscopic coating technologies that enable better outcomes for its customers’ products and processes.

For further information, visit

Safe Harbor Statement 

We discuss expectations regarding our future performance, such as our business outlook, in our annual and quarterly reports, press releases, and other written and oral statements. These “forward-looking statements” are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations. These factors include, among other considerations, general economic and business conditions; political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; the duration and scope of the COVID-19 pandemic; the extent and duration of the pandemic’s adverse effect on economic and social activity, consumer confidence, discretionary spending and preferences, labor and healthcare costs, and unemployment rates, any of which may reduce demand for some of our products and impair the ability of those with whom we do business to satisfy their obligations to us; our ability to sell and provide our services and products, including as a result of continued pandemic related travel restrictions, mandatory business closures, and stay-at home or similar orders; any temporary reduction in our workforce, closures of our offices and facilities and our ability to adequately staff and maintain our operations resulting from the pandemic; the ability of our customers and suppliers to continue their operations as result of the pandemic, which could result in terminations of contracts, losses of revenue, and further adverse effects to our supply chain; maintenance of increased order backlog, including effects of any COVID-19 related cancellations; the imposition of tariffs; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; consummation of order proposals; completion of large orders on schedule and on budget; continued sales growth in the specialty glass and portable electronics markets; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of quarterly revenues within the forecasted range. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-K and Form 10-Qs containing additional important information.

For more information, contact:

Stephen Bagley
Chief Financial Officer
Sono-Tek Corporation 

Investor Relations:
Stephanie Prince
PCG Advisory
(646) 762-4518


  February 29, 2020  February 28, 2019 
Current Assets:        
Cash and cash equivalents $3,659,551  $3,144,123 
Marketable securities  4,219,240   2,365,706 
Accounts receivable (less allowance of $71,000 and $46,000, respectively)  929,701   1,397,891 
Inventories, net  2,381,891   1,658,016 
Prepaid expenses and other current assets  153,698   395,005 
Total current assets  11,344,081   8,960,741 
Land  250,000   250,000 
Buildings, net  1,654,061   1,731,547 
Equipment, furnishings and leasehold improvements, net  1,212,578   802,932 
Intangible assets, net  106,291   122,941 
Deferred tax asset  176,314   332,017 
TOTAL ASSETS $14,743,325  $12,200,178 
Current Liabilities:        
Accounts payable $668,721  $585,694 
Accrued expenses  1,613,409   632,706 
Customer deposits  1,648,690   1,149,558 
Current maturities of long term debt  169,716   162,816 
Income taxes payable  70,621   6,272 
Total current liabilities  4,171,157   2,537,046 
Deferred tax liability  251,761   370,757 
Long term debt, less current maturities  538,000   707,715 
Total Liabilities  4,960,918   3,615,518 
Commitments and Contingencies      
Stockholders’ Equity        
Common stock, $.01 par value; 25,000,000 shares authorized, 15,348,180 and 15,197,563 issued and outstanding, respectively  153,482   151,976 
Additional paid-in capital  9,018,406   8,929,607 
Accumulated earnings (deficit)  610,519   (496,923)
Total stockholders’ equity  9,782,407   8,584,660 

See notes to consolidated financial statements.


  Fiscal Year Ended 
  February 29, 2020  February 28, 2019 
Net Sales $15,354,619  $11,609,599 
Cost of Goods Sold  8,041,378   6,361,353 
Gross Profit  7,313,241   5,248,246 
Operating Expenses        
Research and product development  1,427,543   1,324,766 
Marketing and selling  3,403,133   2,686,382 
General and administrative  1,367,073   1,154,611 
Total Operating Expenses  6,197,749   5,165,759 
Operating Income  1,115,492   82,487 
Other Income (Expense):        
Interest Expense  (33,038)  (39,977)
Interest and Dividend Income  101,592   136,677 
Realized gain on sale of marketable securities     73,699 
Net unrealized loss on marketable securities     (100,184
Other Income  29,401   28,732 
Income before Income Taxes  1,213,447   181,434 
Income Tax Expense  106,005   19,847 
Net Income $1,107,442  $161,587 
Basic Earnings Per Share $.07  $.01 
Diluted Earnings Per Share $.07  $.01 
Weighted Average Shares – Basic  15,302,367   15,107,778 
Weighted Average Shares – Diluted  15,359,088   15,218,913 

See notes to consolidated financial statements.


  Fiscal Year Ended 
  February 29, 2020  February 28, 2019 
Net Income $1,107,442  $161,587 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:        
Depreciation and amortization  406,731   332,147 
Stock based compensation expense  90,305   30,548 
Bad debt expense  25,000    
Inventory reserve  (77,098  66,000 
Unrealized loss on marketable securities     100,184 
Deferred tax expense  36,707   49,743 
(Increase) Decrease in:        
Accounts receivable  443,190   (623,113
Inventories  (646,777)  (369,933)
Prepaid expenses and other assets  241,307   (255,599)
(Decrease) Increase in:        
Accounts payable and accrued expenses  1,063,730   (327,655
Customer deposits  499,132   805,460 
Income taxes payable  64,349   (78,349
Net Cash Provided by (Used In) Operating Activities  3,254,018   (108,980
Purchase of equipment, furnishings and leasehold improvements  (722,241)  (547,251)
Sale (purchase) of marketable securities  (1,853,534  1,940,010 
Net Cash (Used In) Provided By Investing Activities  (2,575,775  1,392,759 
Repayment of long-term debt  (162,815)  (156,120)
Net Cash (Used In) Financing Activities  (162,815)  (156,120)
Beginning of year  3,144,123   2,016,464 
End of year $3,659,551  $3,144,123 
Supplemental Cash Flow Disclosure:        
Interest Paid $33,038  $39,977 
Income Taxes Paid $4,948  $28,178 

See notes to consolidated financial statements.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.